GlassScriptPhysician profile
Sai Garapati
NPI 1255968186
$20,548.64
in general payments reported to CMS, 2019-2025
22 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.20 · 2023: $501 · 2024: $5,821 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $9,432 · Education: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,529.12 |
| Food and Beverage | $9,431.62 |
| Education | $573.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,339.89 | 2023-2025 | Corevalve Evolut R, Micra, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $3,797.11 | 2025 | |
| Biosense Webster, INC. | $3,659.92 | 2024-2025 | Carto 3 |
| Boston Scientific Corporation | $1,908.77 | 2024-2025 | Accolade Sr, Watchman Flx, Ekosonic |
| Medical Device Business Services, INC. | $1,661.18 | 2024-2025 | Carto 3, Dermabond |
| Abbott Laboratories | $477.45 | 2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Triclip |
| Philips North America LLC | $414.71 | 2023-2024 | (6342) Intrasight Integrated, (Bq9) Coronary Ivus |
| Amgen INC. | $399.33 | 2024-2025 | Repatha, Repatha |
| Abiomed | $349.41 | 2025 | |
| Edwards Lifesciences Corporation | $318.68 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.04 | 2022-2025 | Jardiance |
| Pfizer INC. | $196.78 | 2023-2024 | |
| Ethicon US, LLC | $182.62 | 2025 | Stratafix, Ethicon, Vistaseal |
| Bridgebio Pharma, INC. | $182.02 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $93.49 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $70.10 | 2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $50.85 | 2024-2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $46.63 | 2025 | Camzyos |
| Lantheus Medical Imaging, INC. | $37.64 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $28.25 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2025 | |
| Terumo Medical Corporation | $16.40 | 2024 | Tr Band, Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sai Garapati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.